Related Experiment Video
Updated: Oct 5, 2025

Utilizing Percutaneous Ventricular Assist Devices in Acute Myocardial Infarction Complicated by Cardiogenic Shock
Published on: June 12, 2021
Validation of cardiogenic shock phenotypes in a mixed cardiac intensive care unit population
Jacob C Jentzer1,2, Sabri Soussi3,4, Patrick R Lawler5,6
1Department of Cardiovascular Medicine, Mayo Clinic, Rochester, Minnesota, USA.
Insights
This study validates cardiogenic shock (CS) phenotypes in a cardiac intensive care unit (CICU) population. Identified clusters showed a clear gradient in mortality, improving risk stratification beyond current measures.
Area of Science:
- Cardiology
- Intensive Care Medicine
- Machine Learning in Healthcare
Background:
- Unsupervised machine learning identified distinct phenotypes in cardiogenic shock (CS) populations.
- Validation of these phenotypes in a mixed cardiac intensive care unit (CICU) population is crucial for clinical application.
Purpose of the Study:
- To validate previously proposed CS phenotypes in a real-world CICU patient cohort.
- To assess the association of these phenotypes with in-hospital and 1-year mortality.
Main Methods:
- K-means clustering was applied to 1498 CS patients using admission laboratory values.
- Patients were categorized into three clusters: noncongested, cardiorenal, and hemometabolic.
- Logistic regression and Cox proportional-hazards models analyzed mortality outcomes.
Main Results:
- Three distinct CS phenotypes (noncongested, cardiorenal, hemometabolic) were identified in 1498 CICU patients.
- The hemometabolic cluster (Cluster 3) exhibited the greatest illness severity and significantly higher in-hospital mortality (aOR 2.6 vs. Cluster 1).
- A clear incremental gradient in 1-year mortality was observed across the clusters (Cluster 3 > Cluster 2 > Cluster 1).
Conclusions:
- The study successfully validated distinct CS phenotypes in a mixed CICU population.
- These identified phenotypes demonstrate a mortality gradient, offering improved risk stratification for CS patients.
- Clinical identification of these phenotypes can enhance patient management and outcomes beyond standard risk assessment tools.
Background:
Proposed phenotypes have recently been identified in cardiogenic shock (CS) populations using unsupervised machine learning clustering methods. We sought to validate these phenotypes in a mixed cardiac intensive care unit (CICU) population of patients with CS.
Methods:
We included Mayo Clinic CICU patients admitted from 2007 to 2018 with CS. Agnostic K means clustering was used to assign patients to three clusters based on admission values of estimated glomerular filtration rate, bicarbonate, alanine aminotransferase, lactate, platelets, and white blood cell count. In-hospital mortality and 1-year mortality were analyzed using logistic regression and Cox proportional-hazards models, respectively.
Results:
We included 1498 CS patients with a mean age of 67.8 ± 13.9 years, and 37.1% were females. The acute coronary syndrome was present in 57.3%, and cardiac arrest was present in 34.0%. Patients were assigned to clusters as follows: Cluster 1 (noncongested), 603 (40.2%); Cluster 2 (cardiorenal), 452 (30.2%); and Cluster 3 (hemometabolic), 443 (29.6%). Clinical, laboratory, and echocardiographic characteristics differed across clusters, with the greatest illness severity in Cluster 3. Cluster assignment was associated with in-hospital mortality across subgroups. In-hospital mortality was higher in Cluster 3 (adjusted odds ratio [OR]: 2.6 vs. Cluster 1 and adjusted OR: 2.0 vs. Cluster 2, both p < 0.001). Adjusted 1-year mortality was incrementally higher in Cluster 3 versus Cluster 2 versus Cluster 1 (all p < 0.01).
Conclusions:
We observed similar phenotypes in CICU patients with CS as previously reported, identifying a gradient in both in-hospital and 1-year mortality by cluster. Identifying these clinical phenotypes can improve mortality risk stratification for CS patients beyond standard measures.
Related Concept Videos
Cardiomyopathy II: Dilated Cardiomyopathy
Heart Failure IV: Classification and Diagnostic Evaluation
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Cardiomyopathy I: Introduction and Classification
Acute Coronary Syndrome III: Diagnostic Studies
Cardiomyopathy V: Interprofessional Care

